Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20200430003
TCTR20200430003
Completed
Phase 3

The comparison of nasal irrigation outcome between 3% NaCl and 0.9% NaCl in adult allergic rhinitis: a randomized double-blind study

Phayao Hospital0 sites80 target enrollmentApril 30, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsadult allergic rhinitisnasal irrigation3%NaCl0.9%NaClhypertonic salineallergic rhinitis

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
adult allergic rhinitis
Sponsor
Phayao Hospital
Enrollment
80
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 30, 2020
End Date
June 30, 2019
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\.adult age \>15 year old
  • •2\.allergic rhinitis patients who were diagnosed according to ARIA guideline
  • •3\.active nasal symptoms more than a week

Exclusion Criteria

  • •1\.present with symptoms of bacteria infection
  • •2\.evidence of nasal anatomical variation or neoplasm
  • •3\.evidence of chronic disease
  • •4\.history of smoking
  • •5\.history of sinonasal surgery
  • •6\.history of nasal irrigation or topical nasal steroid spray within 1 month before study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
effects of nasal lavage using solutions of hypertonic saline, isotonic saline and hypotonic saline in treating the symptoms of chronic sinusitisChronic sinusitis.Chronic sinusitis
IRCT2015021020320N2Vice Chancellor of Ahvaz Jondishapour University of Medical Sciences185
Active, not recruiting
Not Applicable
Examination of the effect of nasal irrigation in patients with cedar pollinosiscedar pollinosiscedar, pollinosis1006
JPRN-jRCTs052220146Masafumi Sakashita45
Completed
Not Applicable
A comparative study of humidification and a nasal spray for the treatment of nasal symptoms experienced by patients using continuous positive airway pressure (CPAP) via a maskervous System Diseases: obstructive sleep apnoea (OSA)Nervous System DiseasesObstructive sleep apnoea (OSA)
ISRCTN75033377Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)32
Recruiting
Not Applicable
Effect of neogard protection to reduce nasal injury in preterm infants receiving N-CPAP
IRCT20191217045769N1Esfahan University of Medical Sciences80
Completed
Not Applicable
Comparison of the effectiveness of nasal continuous positive airway pressure (NCPAP) therapy with combination of High-Frequency Oscillations and NCPAP in treatment of respiratory distress syndrome in infantsRespiratory distress syndrome.Respiratory distress syndrome of newbornP22.0
IRCT20180915041040N3Shahre-kord University of Medical Sciences40